Philadelphia September 9, 2002—Magee Rehabilitation Hospital announced today that it has learned of a serious shortage of the drug Baclofen (also known by the trade name Lioresal). Baclofen is a drug taken orally in tablet form by individuals with various neurologic injuries and diseases, including: spinal cord injury, stroke, multiple sclerosis, and cerebral palsy.

Baclofen used in implanted pumps appears to be unaffected by this shortage.

The drug is used to alleviate symptoms of spasticity (involuntary muscle contractions and spasms).

The shortage of the drug, according to its three generic manufacturers, is due to a raw materials shortage. Future supplies may not be available until January, 2003. Individuals may not be easily weaned off the drug, and if Baclofen is suddenly unavailable to users, the consequences can range from increased spasticity to delirium, seizures and even death.

Magee Rehabilitation Hospital advises individuals using oral Baclofen to check with their pharmacy regarding its availability. Individuals unable to obtain oral Baclofen should contact their prescribing physician on how to proceed.